Competition Law360 provides breaking news and analysis on antitrust law. Coverage includes high-stakes antitrust litigation and government enforcement actions, as well as legislative and regulatory developments.

Sign up for a 7-day FREE trial today!

Latest News in Competition

• September 02, 2025

  Visa, Mastercard Still Can't Beat Intuit, Block Antitrust Claims

  A New York federal judge has rejected Visa and Mastercard's latest effort to ditch antitrust claims brought by Intuit and Block in long-running multidistrict litigation over payment processing fees, agreeing with a magistrate judge's finding that the court has already considered and rejected the credit companies' arguments.

• September 02, 2025

  Amazon Judge Unseals Ruling Certifying Huge Antitrust Class

  A largely unredacted version of a Washington federal judge's order certifying a class of roughly 300 million consumers in a sweeping antitrust case accusing the e-commerce giant of inflating prices through its merchant policies was filed Friday, offering a window into the court's viewpoints after the initial order was sealed.

• September 02, 2025

  Speculation Can't Halt Medical Coatings Merger, GTCR Says

  GTCR BC Holdings LLC should be allowed to merge the nation's leading medical coatings supplier with the second leading provider because federal regulators spent two weeks simply relying on speculation and theory to prove its losing antitrust case, the private equity subsidiary argued.

• September 02, 2025

  Wall Street Banks Beat Revived Bond-Rigging Antitrust Claims

  A New York federal judge tossed a recently revived proposed antitrust class action Tuesday accusing Bank of America Corp., Wells Fargo & Co. and other major financial institutions of conspiring to rig corporate bonds and boycott rival bond-trading platforms, finding the allegations are vague, conclusory and time-barred.

• September 02, 2025

  $33M Pfizer Antitrust Deal OK'd, First MDL Trial Date Set

  A Pennsylvania federal judge has granted preliminary approval for a $33 million settlement between Pfizer and a class of direct purchasers claiming it fixed the prices of generic drugs, while also setting a date for the first bellwether trial in the antitrust litigation.

See more Competition news